Evidence map›Paper›PMID 26575629›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells.

Antoine Tanne, Luciana R Muniz, Anna Puzio-Kuter, Katerina I Leonova, Andrei V Gudkov, David T Ting, Rémi Monasson, Simona Cocco, Arnold J Levine, Nina Bhardwaj and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Perspectives of long non-coding RNAs in cancer.Molecular biology reports · 2017
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Alpha Satellite DNA in Targeted Drug Therapy for Prostate Cancer.International journal of molecular sciences · 2023
    Article
  13. Article
  14. Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Antoine TanneTisch Cancer Institute, Department of Medicine, Hematology, and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Luciana R MunizTisch Cancer Institute, Department of Medicine, Hematology, and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Anna Puzio-KuterRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903;
Katerina I LeonovaRoswell Park Cancer Institute, Buffalo, NY 14263;
Andrei V GudkovRoswell Park Cancer Institute, Buffalo, NY 14263;
David T TingMassachusetts General Hospital, Charlestown, MA 02129;
Rémi MonassonLaboratoire de Physique Théorique, CNRS and Ecole Normale Supérieure, 75005 Paris, France;
Simona CoccoLaboratoire de Physique Statistique, CNRS and Ecole Normale Supérieure, 75005 Paris, France;
Arnold J LevineRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903; The Simons Center for Systems Biology, School of Natural Sciences, Institute for Advanced Study, Princeton, NJ 08540; alevine@ias.edu benjamin.greenbaum@mssm.edu.
Nina BhardwajTisch Cancer Institute, Department of Medicine, Hematology, and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Benjamin D GreenbaumTisch Cancer Institute, Department of Medicine, Hematology, and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; The Simons Center for Systems Biology, School of Natural Sciences, Institute for Advanced Study, Princeton, NJ 08540; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029 alevine@ias.edu benjamin.greenbaum@mssm.edu.
Icahn School of Medicine at Mount Sinai · USCentre National de la Recherche Scientifique · FRRoswell Park Comprehensive Cancer Center · USCenter for Systems Biology · USInstitute for Advanced Study · USMassachusetts General Hospital · USRutgers Cancer Institute · US

Funding

Scientific ReagentsP01CA087497 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2000 to 2021
$35.4M
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Modulating anti-HIV immunity by plasmacytoid dendritic cellsR01AI081848 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BHARDWAJ, NINA · 2010 to 2021
$4.5M
Matrix metalloproteinase-2 modulates inflammation via TLR2R01CA180913 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BHARDWAJ, NINA · 2014 to 2018
$1.8M
NCI NIH HHS 1R01CA180913-01A1NCI NIH HHS 5P01CA087497-13NCI NIH HHS K12 CA087723NCI NIH HHS K12CA087723-11A1NCI NIH HHS P01 CA087497NCI NIH HHS R01 CA180913NIAID NIH HHS 5R01AI081848-05NIAID NIH HHS R01 AI081848
6 · The paper itself

Abstract

Recent studies have demonstrated abundant transcription of a set of noncoding RNAs (ncRNAs) preferentially within tumors as opposed to normal tissue. Using an approach from statistical physics, we quantify global transcriptome-wide motif use for the first time, to our knowledge, in human and murine ncRNAs, determining that most have motif use consistent with the coding genome. However, an outlier subset of tumor-associated ncRNAs, typically of recent evolutionary origin, has motif use that is often indicative of pathogen-associated RNA. For instance, we show that the tumor-associated human repeat human satellite repeat II (HSATII) is enriched in motifs containing CpG dinucleotides in AU-rich contexts that most of the human genome and human adapted viruses have evolved to avoid. We demonstrate that a key subset of these ncRNAs functions as immunostimulatory "self-agonists" and directly activates cells of the mononuclear phagocytic system to produce proinflammatory cytokines. These ncRNAs arise from endogenous repetitive elements that are normally silenced, yet are often very highly expressed in cancers. We propose that the innate response in tumors may partially originate from direct interaction of immunogenic ncRNAs expressed in cancer cells with innate pattern recognition receptors, and thereby assign a previously unidentified danger-associated function to a set of dark matter repetitive elements. These findings potentially reconcile several observations concerning the role of ncRNA expression in cancers and their relationship to the tumor microenvironment.

Indexed as

AnimalsHumansImmunity, InnateMiceNeoplasmsRNA, UntranslatedRNA, Untranslatedcancer immunologygenome evolutionnoncoding RNA

Identifiers

PMID26575629
PMCPMC4679042
OpenAlexW1892467251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.